- Transactions
- M&A / Private Equity
- The 14 June 2022
Yards advises XAnge, Omnes and Quantonation in the €16 million fundraising of Qubit Pharmaceuticals
BackLaw firm Yards advised Xange as well as Omnes and Quantonation in the €16 million fundraising of Qubit Pharmaceuticals, which was also subscribed by Octave Klaba (founder of OVH).
This fundraising operation will enable the company, which created a platform for the discovery of new treatments using quantum physics, to finance the building of its portfolio to ten research programmes on cancer and inflammatory diseases.
The Yards team consisted of Jean-Philippe Jacob, partner, Julien Brouwer, counsel, and Kamélia Kerchi, associate.
Keys Avocats and Altaïr Avocats acted as counsel to Qubit Pharmaceuticals.
Jeausserand Audouard acted as counsel to the founders of Qubit Pharmaceuticals.
Expertise
News M&A / Private Equity
-
- M&A / Private Equity
- Transactions
Yards advises BlaBlaCar on the acquisition of Klaxit
-
- M&A / Private Equity
- Transactions
Yards supports Proxistore in its acquisition of a majority stake in the French start-up Sirdata
-
- M&A / Private Equity
- Transactions
Yards supports Oasys & Cie in the acquisition of Alquier Communication